Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Taienkang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Guangdong Taienkang Pharmaceutical Co., Ltd., is a high-tech pharmaceutical company specializing in the research, development, manufacturing, and marketing of oral solid preparations and traditional Chinese medicines. Founded in 1992 and acquired by Guangdong Taienkang in 2015, the company operates a modern production base in Ma'anshan, Anhui Province, along with a branch in Bozhou focused on Chinese herbal pieces and refined extracts. Its commercial portfolio includes over 30 varieties, highlighted by the exclusive Compound Black Chicken Pill and the recently approved Hewei Zhengchang Pills and Bilastine tablets. Anhui Taienkang is actively expanding its generic and innovative drug pipeline, with multiple programs in bioequivalence clinical trials targeting central nervous system disorders, metabolic diseases, and chronic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Taienkang Pharmaceutical.